Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis

BACKGROUND: The refractory/relapsed multiple myeloma (RRMM) remains a big clinical challenge, due to its biological and clinical complexity. Leading hematologists have performed many randomized controlled trials (RCTs) worldwide, and their findings were summarized in a recently published network met...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xian-Wu, Du, Xue-Qing, Li, Jie-Li, Liu, Xiao-Ping, Meng, Xiang-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109665/
https://www.ncbi.nlm.nih.gov/pubmed/30174457
http://dx.doi.org/10.2147/CMAR.S166640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109665/
https://www.ncbi.nlm.nih.gov/pubmed/30174457
http://dx.doi.org/10.2147/CMAR.S166640

Ejemplares similares